• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Taiwan, China starts study on efficacy of mixing AZ, Moderna COVID vaccines

firstwordpharmaAugust 02, 2021

Tag: AZ , Moderna , COVID vaccines

A hospital in Taiwan, China has begun a clinical study investigating a mix and match approach with COVID-19 vaccines from AstraZeneca and Moderna, Taiwan, China News reported.

Taiwan, China starts study on efficacy of mixing AZ, Moderna COVID vaccines

The trial, which is being carried out by the National Taiwan, China University Hospital (NTUH), includes four groups of 100 subjects, with the first two receiving doses of AstraZeneca and Moderna's vaccines four or eight weeks apart.

Meanwhile, the third group will receive two doses of AstraZeneca's vaccine eight weeks apart, with the final group given two doses of Moderna's vaccine, also eight weeks apart


Previous:Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

Next:UK scientists believe it is 'almost certain' a coronavirus variant will emerge that beats current vaccines

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Taiwan, China starts study on efficacy of mixing AZ, Moderna COVID vaccines | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

5-Bromo-4-nitro-1-propyl-1H-pyrazole

5-Bromo-4-nitro-1-propyl-1H-pyrazole
3-Bromo-N-phenylcarbazole

3-Bromo-N-phenylcarbazole
ACEPROMAZINE MALEATE

ACEPROMAZINE MALEATE
METRONIDAZOLE

METRONIDAZOLE

Azelnidipine

Azelnidipine
1H-PYRAZOLE-4-BORONIC ACID PINACOL ESTER

1H-PYRAZOLE-4-BORONIC ACID PINACOL ESTER
(1R,2S,5S)-methyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylate hydrochloride

(1R,2S,5S)-methyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylate hydrochloride
99% up by HPLC VONOPRAZAN FUMARATE 1260141-27-2

99% up by HPLC VONOPRAZAN FUMARATE 1260141-27-2
Adipic dihydrazide(ADH)

Adipic dihydrazide(ADH)
1,2,3-triazole

1,2,3-triazole

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service